Immix Biopharma | Investor Presentation Deck | 57 slides · page 29 of 57
The table displays clinical trial data for NXC-201, specifically focusing on safety profiles and management interventions.
Pitch deck · appendix_data · analyze_data · balanced density
Slide locked Sign in to view
Slide schematic 3/3
disclaimer 1/1 table 1/1 title 1/1
Components 3
disclaimer data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.